Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Breast Cancer

Free Subscription Articles published in Eur J Cancer Retrieve available abstracts of 68 articles: HTML format Text format

Single Articles

February 2010
1. ZENG Q , Yang Z, Gao YJ, Yuan H, et al
   Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: An in vivo bioluminescence imaging study.
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
2. SHARPE KH , McClements P, Clark DI, Collins J, et al
   Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy.
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. LARSSON SC , Bergkvist L, Wolk A
   Dietary carotenoids and risk of hormone receptor-defined breast cancer in a prospective cohort of Swedish women.
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. KALLSTROM AC , Salme R, Ryden L, Nordenskjold B, et al
   17ss-Hydroxysteroid dehydrogenase type 1 as predictor of tamoxifen response in premenopausal breast cancer.
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
5. LEE CK , Lord SJ, Stockler MR, Coates AS, et al
   Historical cross-trial comparisons for competing treatments in advanced breast cancer - An empirical analysis of bias.
   Eur J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. NG W , Delaney GP, Jacob S, Barton MB, et al
   Estimation of an optimal chemotherapy utilisation rate for breast cancer: Setting an evidence-based benchmark for the best-quality cancer care.
   Eur J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. MCCLOSKEY E , Paterson A, Kanis J, Tahtela R, et al
   Effect of oral clodronate on bone mass, bone turnover and subsequent metastases in women with primary breast cancer.
   Eur J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. RUCKHABERLE E , Karn T, Engels K, Turley H, et al
   Prognostic impact of thymidine phosphorylase expression in breast cancer - Comparison of microarray and immunohistochemical data.
   Eur J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. AGBORSANGAYA CB , Surcel HM, Toriola AT, Pukkala E, et al
   Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study.
   Eur J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
10. GREUTER MJ , Jansen-van der Weide MC, Jacobi CE, Oosterwijk JC, et al
    The validation of a simulation model incorporating radiation risk for mammography breast cancer screening in women with a hereditary-increased breast cancer risk.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SHARP DM , Walker MB, Chaturvedi A, Upadhyay S, et al
    A randomised, controlled trial of the psychological effects of reflexology in early breast cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
12. EIERMANN W , Graf E, Ataseven B, Conrad B, et al
    Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) - The German Adjuvant Breast Cancer Group.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. ROSENDAHL M , Ahlgren J, Andersen J, Bergh J, et al
    The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: Data from the randomised SBG 2000-1 study.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. BLAMEY RW , Hornmark-Stenstam B, Ball G, Blichert-Toft M, et al
    ONCOPOOL - A European database for 16,944 cases of breast cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. PEDERSEN CG , Christensen S, Jensen AB, Zachariae R, et al
    Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
16. SOUSA-JUNIOR EC , Alencar AP, da Silva BB
    Analysis of Ki-67 and Bcl-2 protein expression in normal colorectal mucosa of women with breast cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. VARADI V , Brendle A, Brandt A, Johansson R, et al
    Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. LU W , Schaapveld M, Jansen L, Bagherzadegan E, et al
    The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. CHAN A , Verrill M
    Capecitabine and vinorelbine in metastatic breast cancer.
    Eur J Cancer. 2009;45:2253-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. STRAVER ME , Rutgers EJ, Russell NS, Oldenburg HS, et al
    Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer.
    Eur J Cancer. 2009;45:2284-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. SCHMIDT MK , Vermeulen E, Tollenaar RA, Van't Veer LJ, et al
    Regulatory aspects of genetic research with residual human tissue: effective and efficient data coding.
    Eur J Cancer. 2009;45:2376-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. MANSEL R
    An update of sentinel node biopsy in breast cancer.
    Eur J Cancer. 2009;45 Suppl 1:447-8.
    PubMed     Text format     Related articles   
    
    
    
23. CORREA CR , Darby SC
    Cardiac disease and second lung cancer after radiotherapy for breast cancer.
    Eur J Cancer. 2009;45 Suppl 1:420-1.
    PubMed     Text format     Related articles   
    
    
    
24. PUNTONI M , Decensi A
    The rationale and potential of cancer chemoprevention with special emphasis on breast cancer.
    Eur J Cancer. 2009;45 Suppl 1:346-54.
    PubMed     Text format     Related articles   
    
    
    
25. GRONER B , Vafaizadeh V, Brill B, Klemmt P, et al
    Mammary epithelial and breast cancer stem cells.
    Eur J Cancer. 2009;45 Suppl 1:186-93.
    PubMed     Text format     Related articles   
    
    
    
26. LINN SC , Van 't Veer LJ
    Clinical relevance of the triple-negative breast cancer concept: genetic basis and clinical utility of the concept.
    Eur J Cancer. 2009;45 Suppl 1:11-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. VIALE G , Bottiglieri L
    Pathological definition of triple negative breast cancer.
    Eur J Cancer. 2009;45 Suppl 1:5-10.
    PubMed     Text format     Related articles   
    
    
    August 2009
28. VAN DEURZEN CH , Vriens BE, Tjan-Heijnen VC, van der Wall E, et al
    Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: A systematic review.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. PIVOT XB , Li RK, Thomas ES, Chung HC, et al
    Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. TUTHILL M , Pell R, Guiliani R, Lim A, et al
    Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis.
    Eur J Cancer. 2009;45:2146-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. NAKAMURA R , Sakakibara M, Nagashima T, Sangai T, et al
    Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer.
    Eur J Cancer. 2009;45:2123-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
32. SCHMITT M , Sweep FC
    Tissue inhibitor metalloproteinase type-1 (TIMP-1), a novel cancer biomarker predicting response of adjuvant anthracycline-based chemotherapy in patients afflicted with primary breast cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
33. AAPRO M , Barnadas A, Leonard RC, Marangolo M, et al
    What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. DAS K , Leong DT, Gupta A, Shen L, et al
    Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. JASSEM J , Carroll C, Ward SE, Simpson E, et al
    The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: A systematic review.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. BRAUCH H , Jordan VC
    Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: The 'personalised' approach?
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. BONNEFOI H , Underhill C, Iggo R, Cameron D, et al
    Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic?
    Eur J Cancer. 2009;45:1733-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. COLEMAN RE
    Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?
    Eur J Cancer. 2009;45:1909-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. SCHOPPER D , de Wolf C
    How effective are breast cancer screening programmes by mammography? Review of the current evidence.
    Eur J Cancer. 2009;45:1916-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. DAHLBERG L , Lundkvist J, Lindman H
    Health care costs for treatment of disseminated breast cancer.
    Eur J Cancer. 2009;45:1987-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. VINCENT-SALOMON A , Caly M, De Rycke Y, Freneaux P, et al
    Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma.
    Eur J Cancer. 2009;45:1979-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. RAKHA EA , Aleskandarany M, El-Sayed ME, Blamey RW, et al
    The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.
    Eur J Cancer. 2009;45:1780-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
43. MAGNUSSON M , Hoglund P, Johansson K, Jonsson C, et al
    Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. PARR C , Jiang WG
    Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
    Eur J Cancer. 2009;45:1673-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. LIU CQ , Guo Y, Shi JY, Sheng Y, et al
    Late morbidity associated with a tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review.
    Eur J Cancer. 2009;45:1560-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. DAMMAN OC , Hendriks M, Sixma HJ
    Towards more patient centred healthcare: A new Consumer Quality Index instrument to assess patients' experiences with breast care.
    Eur J Cancer. 2009;45:1569-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
47. SESSA C , Perotti A, Noberasco C, De Braud F, et al
    Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer.
    Eur J Cancer. 2009;45:1153-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
48. VON MINCKWITZ G , Schwenkglenks M, Skacel T, Lyman GH, et al
    Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: results from an integrated analysis.
    Eur J Cancer. 2009;45:608-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. DIXON JM , Mak C, Radhakrishna S, Kehoe T, et al
    Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer.
    Eur J Cancer. 2009;45:795-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. LI Y , Baer D, Friedman GD, Udaltsova N, et al
    Wine, liquor, beer and risk of breast cancer in a large population.
    Eur J Cancer. 2009;45:843-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. JAKUBOWSKA A , Jaworska K, Cybulski C, Janicka A, et al
    Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?
    Eur J Cancer. 2009;45:837-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. LONNING PE
    Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation?
    Eur J Cancer. 2009;45:527-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. GIANNI L , Gelber S, Ravaioli A, Price KN, et al
    Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.
    Eur J Cancer. 2009;45:561-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. DUIJM LE , Groenewoud JH, de Koning HJ, Coebergh JW, et al
    Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
    Eur J Cancer. 2009;45:774-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. PEUCKMANN V , Ekholm O, Sjogren P, Rasmussen NK, et al
    Health care utilisation and characteristics of long-term breast cancer survivors: nationwide survey in Denmark.
    Eur J Cancer. 2009;45:625-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. FIELD KM , Jenkins MA, Friedlander ML, McKinley JM, et al
    Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer.
    Eur J Cancer. 2009;45:551-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
57. PARKIN DM
    Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. RODY A , Karn T, Ruckhaberle E, Hanker L, et al
    Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.
    Eur J Cancer. 2009;45:405-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. NAPOLEONE E , Zurlo F, Latella MC, Amore C, et al
    Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells.
    Eur J Cancer. 2009;45:470-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. NALDINI A , Filippi I, Ardinghi C, Silini A, et al
    Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells.
    Eur J Cancer. 2009;45:454-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. BRENDLE A , Brandt A, Johansson R, Enquist K, et al
    Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.
    Eur J Cancer. 2009;45:435-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. ALEXANDER S , Minton O, Andrews P, Stone P, et al
    A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome.
    Eur J Cancer. 2009;45:384-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
63. HALL PS , Cameron DA
    Current perspective - trastuzumab.
    Eur J Cancer. 2009;45:12-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. DE GELDER R , Bulliard JL, de Wolf C, Fracheboud J, et al
    Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
    Eur J Cancer. 2009;45:127-38.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. SPAN PN , Sieuwerts AM, Heuvel JJ, Spyratos F, et al
    Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: an EU-FP6 supported study of members of the EORTC - PathoBiology Group.
    Eur J Cancer. 2009;45:74-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. HEIDEMAN WH , Russell NS, Gundy C, Rookus MA, et al
    The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors.
    Eur J Cancer. 2009;45:119-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
67. MICHELSEN TM , Pripp AH, Tonstad S, Trope CG, et al
    Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk of hereditary breast ovarian cancer: A controlled observational study.
    Eur J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
68. ESKENS FA , Sleijfer S
    The use of bevacizumab in colorectal, lung, breast, renal and ovarian cancer: Where does it fit?
    Eur J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: